We are live on ! Find out more
CGNT

Cogentix Medical, Inc.
CGNT

Delisted

CGNT was delisted on the 20th of April, 2018.

38 hedge funds and large institutions have $11.8M invested in Cogentix Medical, Inc. in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $10.8M → $11.8M (+$1M)

0% more funds holding

Funds holding: 3838 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
38
Holders Change
Holders Change %
0%
% of All Funds
1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
6
Reduced
10
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CGNT Hedge Fund Activity: Q4 2015 in Review

38 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q4 2015, worth a combined $11.8M — up 9.3% from $10.8M a quarter earlier.

Fund positioning in CGNT was balanced in Q4 2015: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 10 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $1.79M. The largest seller was Amici Capital, cutting an estimated $704K.

  • 38 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $11.8M of Cogentix Medical, Inc. stock for Q4 2015, up 9.3% quarter-over-quarter.
  • 2 funds opened new Cogentix Medical, Inc. positions in Q4 2015 and 2 closed out, a net change of 0 holders.
  • The largest Cogentix Medical, Inc. buyer in Q4 2015 was Nantahala Capital Management, an estimated $1.79M added.
  • The largest Cogentix Medical, Inc. seller in Q4 2015 was Amici Capital, an estimated $704K sold.

Based on aggregated 13F filings for Q4 2015.